CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Weikang Bio-Technology Group Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Weikang Bio-Technology Group Co Ltd
No. 365 Chengde Street
Daowai District
Phone: +86 45188355530p:+86 45188355530 Harbin, HNG  150020  China Fax: +86 45188355520f:+86 45188355520
On 6/4/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Weikang Bio-Technology Group Co Ltd. for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.
Business Summary
Weikang Bio-Technology Group Co Ltd. (WKBT), formerly Expedition Leasing, Inc., through Heilongjiang Weikang Biotechnology Group Co., Ltd. (Heilongjiang Weikang), is principally engaged in developing, manufacturing and distributing health and nutritional supplements in China. Heilongjiang Weikang is a wholly owned subsidiary of Sinary Bio-Technology Holdings Group, Inc. (Sinary), which is a wholly owned subsidiary of the Company. Heilongjiang Weikang manufactures and distributes a series of internally developed health supplements under a Chinese name, which English transliteration is Rongrun. The Rongrun line of products includes Rongrun Youth Keeping Capsules, Rongrun Energy Keeping Capsules, Rongrun Vitamin Sugar Capsules, Rongrun Intestine Cleansing Capsules and Rongrun Artery Cleansing Capsules. On July 22, 2008, Heilongjiang Weikang acquired Tianfang (Guizhou) Pharmaceutical Co., Ltd. (Tianfang).
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201212/31/2011YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer YinWang 58
Chief Financial Officer BaolinSun 56 7/23/2010 7/23/2010
Director JefferyChuang 4/8/2011 4/8/2011
Director YanHuang 4/7/2010 4/7/2010
Director AllenZhang 58 4/7/2010 4/7/2010

Business Names
Business Name
Expedition Holdings, Inc.
Expedition Leasing, Inc.
Heilongjiang Weikang Bio-Technology Group Co., Ltd.
Sinary Bio-Technology Holdings Group, Inc.
Weikang Bio-Technology Group Co Ltd

General Information
Number of Employees: 425 (As of 3/29/2012)
Outstanding Shares: 35,128,358 (As of 12/5/2012)
Shareholders: 372
Stock Exchange: OTC
Federal Tax Id: 020111291
Fax Number: +86 45188355520
Email Address: info@expeditionleasing.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023